Cell Therapy Human Raw Materials Market Size Report, 2024-2032

Cell Therapy Human Raw Materials Market Share, Size, Trends, Industry Analysis Report, By Product (Cell Culture Media, Cell Culture Supplements, Cell Culture Sera, Reagents & Buffers, Others); By End-User; By Region; Segment Forecast, 2024- 2032

Published Date:Feb-2024
Pages: 117
Format: PDF
Report ID: PM4546
Base Year: 2023
Historical Data: 2019-2022

Report Outlook

cell therapy human raw materials market size was valued at USD 2.94 billion in 2023.
The market is anticipated to grow from USD 3.62 billion in 2024 to USD 19.13 billion by 2032, exhibiting the CAGR of 23.1% during the forecast period.

Market Introduction

The human raw materials in cell therapy is currently experiencing a surge in technological advancements, marked by the development of innovative biomaterials and sophisticated manufacturing processes. These breakthroughs serve to enhance the efficiency and scalability of cell therapy production. Also, there is a noticeable shift towards personalized medicine, placing an increased focus on tailoring cell therapies to individual patient profiles. This evolving trend underscores the imperative for a diverse range of high-quality human raw materials that are essential in supporting the manufacturing of customized cell therapies, eventually contributing to cell therapy human raw materials market growth.

Automation is gaining momentum in the manufacturing processes of cell therapy, aiming to streamline operations and enhance reproducibility. The inclination towards automated workflows in the handling of raw materials reduces the risk of contamination and ensures a consistent approach in cell therapy production.

Cell Therapy Human Raw Materials Market Size

To Understand More About this Research: Request a Free Sample Report

For instance, in May 2023, Lonza introduced the TheraPeak T-Vivo cell culture medium, an innovative chemically defined medium designed to enhance the manufacturing of CAR T cells. Devoid of animal-origin components, this medium enhances consistency and process control, streamlining regulatory approval processes for accelerated time-to-market.

The rising incidence of chronic conditions such as cancer, diabetes, and autoimmune disorders, coupled with a growing demand for regenerative and personalized medicines, increasing research and development initiatives, and a surge in investments, are expected to increase the cell therapy human raw materials market size in the forecast period.

Industry Growth Drivers

Increasing occurrence of chronic ailments is projected to spur the product demand.

The cell therapy human raw materials market growth is greatly aided by the mounting prevalence of chronic conditions, including cancer and diabetes, stands as a significant catalyst for the cell therapy market. Cell therapies present inventive treatment avenues that address the underlying causes of these ailments, thereby amplifying the need for human raw materials.

Favorable Regulatory Landscape is expected to drive cell therapy human raw materials market growth.

Governments and regulatory entities are progressively acknowledging the promise of cell therapies and are streamlining the regulatory framework to facilitate their development and commercialization. A regulatory environment that is supportive fosters investments and expedites the expansion of the cell therapy human raw materials market size.

Cell Therapy Human Raw Material

Industry Challenges

High development cost is likely to impede the market cell therapy human raw materials growth opportunities.

High development cost stand as a prominent factor hindering the growth of the cell therapy human raw materials market. The creation of cell therapies entails substantial research and development expenditures, encompassing costs associated with clinical trials and manufacturing processes. The substantial upfront costs may serve as a hindrance for smaller companies, constraining their engagement in the market.

Moreover, cell therapy manufacturing involves intricate processes demanding precision and adherence to stringent quality benchmarks. The intricacy of production poses challenges in scalability, impacting the cost-effectiveness of cell therapies. Thereby, hindering the cell therapy human raw materials market growth.

Report Segmentation

The market is primarily segmented based on product, end-user, and region.

By Product	By End-User	By Region
Cell Culture Media Cell Culture Supplements Cell Culture Sera Reagents & Buffers Others	Biopharmaceutical & Pharmaceutical Companies CROs & CMOs Academic & Research Institutions	North America (U.S., Canada) Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia) Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea) Latin America (Brazil, Mexico, Argentina) Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

To Understand the Scope of this Report: Speak to Analyst

By Product Analysis

Cell Culture Media segment is expected to witness highest growth during forecast period

The cell culture media segment is projected to grow at a CAGR during the projected period in the cell therapy human raw materials market. This is propelled by various significant factors. Cell culture media provides a controlled and optimized environment with essential nutrients, growth factors, and other critical components necessary for the survival & proliferation of cells. This controlled environment allows researchers and manufacturers to optimize conditions, ensuring the reproducibility & scalability of cell cultures for therapeutic applications. In addition, numerous companies are making substantial investments in the development of cell culture media to enhance the effectiveness of the cell therapy process.

By End-User Analysis

Biopharmaceutical and pharmaceutical companies segment is expected to dominate the cell therapy human raw materials market during forecast period

In 2023, the cell therapy human raw materials market share was predominantly influenced by biopharmaceutical & pharmaceutical companies, commanding a significant market share. The escalating demand for personalized medicine and regenerative treatments has propelled these companies to focus on developing and commercializing cutting-edge cell therapies. Advancements in technology and a supportive regulatory environment have further incentivized biopharmaceutical and pharmaceutical firms to expand their presence in this burgeoning market. The need for high-quality human raw materials, devoid of animal-origin components, is driving strategic partnerships, acquisitions, and intensified research efforts. This dynamic landscape underscores the pivotal role these companies play in shaping the future of cell therapy and underscores the potential for sustained growth in the industry.

Cell Therapy Human Raw Material Seg

Regional Insights

North America region dominated the global cell therapy human raw materials market in 2023

North America dominated the global cell therapy human raw materials market in 2023 and is expected to continue to do so. The prevailing influence of the region can be credited to favorable government regulations, a rising need for groundbreaking therapeutics, and concerted endeavors by major market entities to enhance cell-based therapy products addressing various chronic disorders. Additionally, North America hosts numerous prominent companies engaged in the production and commercialization of cell-based products, creating a surge in demand for cell therapy human raw materials and thereby propelling market expansion. Furthermore, collaborative initiatives between key industry players and smaller biotechnology firms heighten competition, as companies strive to fortify their positions in the dynamically evolving cell therapy market.

In the meanwhile, the Asia Pacific region is poised to experience the most rapid growth in the market. This surge is attributed to a heightened emphasis on biotechnology and a growing demand for advanced cell therapies. The market's expansion is further propelled by increased research and development activities, strategic collaborations, and the establishment of manufacturing facilities by major industry players.

Cell Therapy Human Raw Material Reg

Key Market Players & Competitive Insights

The cell therapy human raw materials market is fragmented and is anticipated to witness competition due to several players' presence. Major service providers in the market are constantly upgrading their technologies to stay ahead of the competition and to ensure efficiency, integrity, and safety. These players focus on partnership, product upgrades, and collaboration to gain a competitive edge over their peers and capture a significant cell therapy human raw materials market share.

Some of the major players operating in the global market include:

Bio-Techne Corporation
Catalent, Inc.
CellGenix GmbH
Corning Incorporated
Lonza Group Ltd.
Merck KGaA
Miltenyi Biotec
Pall Corporation (Danaher Corporation)
PeproTech, Inc.
STEMCELL Technologies Inc.
Takara Bio Inc.
Thermo Fisher Scientific Inc.
WuXi AppTec
ZenBio, Inc.
RoosterBio Inc.

Recent Developments

In January 2024, Solvias, a leading global provider of Chemistry, Manufacturing, and Control (CMC) analytics, disclosed its commitment to conduct analytical release testing services for the groundbreaking CRISPR/Cas9 genome-edited cell therapy. Under a long-term agreement with Vertex Pharmaceuticals, Solvias will contribute its expertise to CASGEVY, the world's first FDA-approved treatment for sickle cell disease (SCD) in patients aged 12 and above experiencing recurrent vaso-occlusive crises. This collaboration underscores Solvias' role in supporting the advancement and quality control of cutting-edge therapies in the field of genetic medicine.
In June 2023, StemCyte revealed the formalization of a collaborative partnership with a prominent U.S. cell therapy enterprise engaged in the creation of allogeneic genetically modified CAR-NK cells derived from umbilical cord blood. Under the agreement, StemCyte commits to providing essential cellular raw materials crucial for the global advancement of allogeneic cell therapy product development.

Report Coverage

The cell therapy human raw materials market report emphasizes on key regions across the globe to provide better understanding of the product to the users. Also, the report provides market insights into recent developments, trends and analyzes the technologies that are gaining traction around the globe. Furthermore, the report covers in-depth qualitative analysis pertaining to various paradigm shifts associated with the transformation of these solutions.

The report provides detailed analysis of the cell therapy human raw materials market size while focusing on various key aspects such as competitive analysis, product, end-user, and their futuristic growth opportunities.

Cell Therapy Human Raw Materials Market Report Scope

Report Attributes	Details
Market size Value in 2024	USD 3.62 billion
Revenue Forecast in 2032	USD 19.13 billion
CAGR	23.1% from 2024 – 2032
Base Year	2023
Historical Data	2019 – 2022
Forecast Period	2024 – 2032
Quantitative Units	Revenue in USD billion and CAGR from 2024 to 2032
Segments Covered	By Product By End-User By Region
Regional Scope	North America Europe Asia Pacific Latin America Middle East & Africa
Competitive Landscape	Cell Therapy Human Raw Materials Market Share Analysis (2023) Company Profiles/Industry participants profiling includes company overview, financial information, product/service benchmarking, and recent developments
Report Format	PDF + Excel
Customization	Report customization as per your requirements with respect to countries, region and segmentation.

FAQ's

What is the expected industry size of Cell Therapy Human Raw Materials Market?

The global cell therapy human raw materials market size is expected to reach USD 19.13 billion by 2032

Who are the top market players in the market?

Corning Incorporated, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec, Pall Corporation are the top market players in the market.

Which region contribute notably towards the global Cell Therapy Human Raw Materials Market?

North America region contribute notably towards the global Cell Therapy Human Raw Materials Market.

What will be the expected CAGR of Cell Therapy Human Raw Materials Market during the forecast period (2023-2032)

Cell Therapy Human Raw Materials Market is exhibiting the CAGR of 23.1% during the forecast period.

What are the key segments in the Cell Therapy Human Raw Materials Market?

The Cell Therapy Human Raw Materials Market report covering key segments are product, end-user, and region

1. Introduction
              1.1. Report Description
                    1.1.1. Objectives of the Study
                    1.1.2. Market Scope
                    1.1.3. Assumptions
              1.2. Stakeholders
2. Executive Summary
              2.1. Market Highlights
3. Research Methodology
              3.1. Overview
                    3.1.1. Data Mining
              3.2. Data Sources
                    3.2.1. Primary Sources
                    3.2.2. Secondary Sources
4. Global Cell Therapy Human Raw Materials Market Insights
              4.1. Cell Therapy Human Raw Materials Market – Industry Snapshot
              4.2. Cell Therapy Human Raw Materials Market Dynamics
                    4.2.1. Drivers and Opportunities
                            4.2.1.1. Increasing occurrence of chronic ailments is projected to spur the product demand.
                            4.2.1.2. Favorable Regulatory Landscape is expected to drive cell therapy human raw materials market growth.
                    4.2.2. Restraints and Challenges
                            4.2.2.1. High development cost is likely to impede the market cell therapy human raw materials growth opportunities.
              4.3. Porter’s Five Forces Analysis
                    4.3.1. Bargaining Power of Suppliers (Moderate)
                    4.3.2. Threats of New Entrants: (Low)
                    4.3.3. Bargaining Power of Buyers (Moderate)
                    4.3.4. Threat of Substitute (Moderate)
                    4.3.5. Rivalry among existing firms (High)
              4.4. PESTLE Analysis
              4.5. Cell Therapy Human Raw Materials Industry trends
              4.6. Value Chain Analysis
              4.7. COVID-19 Impact Analysis
5. Global Cell Therapy Human Raw Materials Market, by Product
              5.1. Key Findings
              5.2. Introduction
                    5.2.1. Global Forklift, by Product, 2019-2032 (USD Billion)
              5.3. Cell Culture Media
                    5.3.1. Global Cell Therapy Human Raw Materials Market, by Cell Culture Media, by Region, 2019-2032 (USD Billion)
              5.4. Cell Culture Supplements
                    5.4.1. Global Cell Therapy Human Raw Materials Market, by Cell Culture Supplements, by Region, 2019-2032 (USD Billion)
              5.5. Cell Culture Sera
                    5.5.1. Global Cell Therapy Human Raw Materials Market, by Cell Culture Sera, by Region, 2019-2032 (USD Billion)
              5.6. Reagents & Buffers
                    5.6.1. Global Cell Therapy Human Raw Materials Market, by Reagents & Buffers, by Region, 2019-2032 (USD Billion)
              5.7. Others
                    5.7.1. Global Cell Therapy Human Raw Materials Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global Cell Therapy Human Raw Materials Market, by End-User
              6.1. Key Findings
              6.2. Introduction
                    6.2.1. Global Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
              6.3. Biopharmaceutical & Pharmaceutical Companies
                    6.3.1. Global Cell Therapy Human Raw Materials Market, by Biopharmaceutical & Pharmaceutical Companies, by Region, 2019-2032 (USD Billion)
              6.4. CROs & CMOs
                    6.4.1. Global Cell Therapy Human Raw Materials Market, by CROs & CMOs, by Region, 2019-2032 (USD Billion)
              6.5. Academic & Research Institutions
                    6.5.1. Global Cell Therapy Human Raw Materials Market, by Academic & Research Institutions, by Region, 2019-2032 (USD Billion)
7. Global Cell Therapy Human Raw Materials Market, by Geography
              7.1. Key findings
              7.2. Introduction
                    7.2.1. Cell Therapy Human Raw Materials Market Assessment, By Geography, 2019-2032 (USD Billion)
              7.3. Cell Therapy Human Raw Materials Market – North America
                    7.3.1. North America: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                    7.3.2. North America: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.3.3. Cell Therapy Human Raw Materials Market – U.S.
                                          7.3.3.1. U.S.: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                                          7.3.3.2. U.S.: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.3.4. Cell Therapy Human Raw Materials Market – Canada
                            7.3.4.1. Canada: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.3.4.2. Canada: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
              7.4. Cell Therapy Human Raw Materials Market – Europe
                    7.4.1. Europe: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                    7.4.2. Europe: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.4.3. Cell Therapy Human Raw Materials Market – UK
                            7.4.3.1. UK: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.4.3.2. UK: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.4.4. Cell Therapy Human Raw Materials Market – France
                            7.4.4.1. France: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.4.4.2. France: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.4.5. Cell Therapy Human Raw Materials Market – Germany
                            7.4.5.1. Germany: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.4.5.2. Germany: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.4.6. Cell Therapy Human Raw Materials Market – Italy
                            7.4.6.1. Italy: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.4.6.2. Italy: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.4.7. Cell Therapy Human Raw Materials Market – Spain
                            7.4.7.1. Spain: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.4.7.2. Spain: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.4.8. Cell Therapy Human Raw Materials Market – Netherlands
                            7.4.8.1. Netherlands: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.4.8.2. Netherlands: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.4.9. Cell Therapy Human Raw Materials Market – Russia
                            7.4.9.1. Russia: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.4.9.2. Russia: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
              7.5. Cell Therapy Human Raw Materials Market – Asia Pacific
                    7.5.1. Asia Pacific: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                    7.5.2. Asia Pacific: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.5.3. Cell Therapy Human Raw Materials Market – China
                            7.5.3.1. China: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.5.3.2. China: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.5.4. Cell Therapy Human Raw Materials Market – India
                            7.5.4.1. India: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.5.4.2. India: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.5.5. Cell Therapy Human Raw Materials Market – Malaysia
                            7.5.5.1. Malaysia: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.5.5.2. Malaysia: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.5.6. Cell Therapy Human Raw Materials Market – Japan
                            7.5.6.1. Japan: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.5.6.2. Japan: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.5.7. Cell Therapy Human Raw Materials Market – Indonesia
                            7.5.7.1. Indonesia: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.5.7.2. Indonesia: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.5.8. Cell Therapy Human Raw Materials Market – South Korea
                            7.5.8.1. South Korea: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.5.8.2. South Korea: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
              7.6. Cell Therapy Human Raw Materials Market – Middle East & Africa
                    7.6.1. Middle East & Africa: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                    7.6.2. Middle East & Africa: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.6.3. Cell Therapy Human Raw Materials Market – Saudi Arabia
                            7.6.3.1. Saudi Arabia: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.6.3.2. Saudi Arabia: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.6.4. Cell Therapy Human Raw Materials Market – UAE
                            7.6.4.1. UAE: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.6.4.2. UAE: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.6.5. Cell Therapy Human Raw Materials Market – Israel
                            7.6.5.1. Israel: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.6.5.2. Israel: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.6.6. Cell Therapy Human Raw Materials Market – South Africa
                            7.6.6.1. South Africa: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.6.6.2. South Africa: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
              7.7. Cell Therapy Human Raw Materials Market – Latin America
                    7.7.1. Latin America: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                    7.7.2. Latin America: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.7.3. Cell Therapy Human Raw Materials Market – Mexico
                            7.7.3.1. Mexico: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.7.3.2. Mexico: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.7.4. Cell Therapy Human Raw Materials Market – Brazil
                            7.7.4.1. Brazil: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.7.4.2. Brazil: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
                    7.7.5. Cell Therapy Human Raw Materials Market – Argentina
                            7.7.5.1. Argentina: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
                            7.7.5.2. Argentina: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
8. Competitive Landscape
              8.1. Expansion and Acquisition Analysis
                    8.1.1. Expansion
                    8.1.2. Acquisitions
              8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
              9.1. Bio-Techne Corporation
                    9.1.1. Company Overview
                    9.1.2. Financial Performance
                    9.1.3. Product Benchmarking
                    9.1.4. Recent Development
              9.2. Catalent, Inc
                    9.2.1. Company Overview
                    9.2.2. Financial Performance
                    9.2.3. Product Benchmarking
                    9.2.4. Recent Development
              9.3. CellGenix GmbH
                    9.3.1. Company Overview
                    9.3.2. Financial Performance
                    9.3.3. Product Benchmarking
                    9.3.4. Recent Development
              9.4. Corning Incorporated
                    9.4.1. Company Overview
                    9.4.2. Financial Performance
                    9.4.3. Product Benchmarking
                    9.4.4. Recent Development
              9.5. Lonza Group Ltd.
                    9.5.1. Company Overview
                    9.5.2. Financial Performance
                    9.5.3. Product Benchmarking
                    9.5.4. Recent Development
              9.6. Merck KGaA
                    9.6.1. Company Overview
                    9.6.2. Financial Performance
                    9.6.3. Product Benchmarking
                    9.6.4. Recent Development
              9.7. Miltenyi Biotec
                    9.7.1. Company Overview
                    9.7.2. Financial Performance
                    9.7.3. Product Benchmarking
                    9.7.4. Recent Development
              9.8. Pall Corporation (Danaher Corporation)
                    9.8.1. Company Overview
                    9.8.2. Financial Performance
                    9.8.3. Product Benchmarking
                    9.8.4. Recent Development
              9.9. PeproTech, Inc.
                    9.9.1. Company Overview
                    9.9.2. Financial Performance
                    9.9.3. Product Benchmarking
                    9.9.4. Recent Development
              9.10. STEMCELL Technologies Inc
                    9.10.1. Company Overview
                    9.10.2. Financial Performance
                    9.10.3. Product Benchmarking
                    9.10.4. Recent Development
              9.11. Takara Bio Inc
                    9.11.1. Company Overview
                    9.11.2. Financial Performance
                    9.11.3. Product Benchmarking
                    9.11.4. Recent Development
              9.12. Thermo Fisher Scientific Inc
                    9.12.1. Company Overview
                    9.12.2. Financial Performance
                    9.12.3. Product Benchmarking
                    9.12.4. Recent Development
              9.13. WuXi AppTec
                    9.13.1. Company Overview
                    9.13.2. Financial Performance
                    9.13.3. Product Benchmarking
                    9.13.4. Recent Development
              9.14. ZenBio, Inc
                    9.14.1. Company Overview
                    9.14.2. Financial Performance
                    9.14.3. Product Benchmarking
                    9.14.4. Recent Development
              9.15. RoosterBio Inc
                    9.15.1. Company Overview
                    9.15.2. Financial Performance
                    9.15.3. Product Benchmarking
                    9.15.4. Recent Development

List of Tables

Table 1 Global Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 2 Global Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 3 Cell Therapy Human Raw Materials Market Assessment, By Geography, 2019-2032 (USD Billion)
Table 4 North America: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 5 North America: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 6 U.S.: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 7 U.S.: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 8 Canada: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 9 Canada: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 10 Europe: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 11 Europe: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 12 UK: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 13 UK: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 14 France: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 15 France: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 16 Germany: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 17 Germany: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 18 Italy: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 19 Italy: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 20 Spain: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 21 Spain: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 22 Netherlands: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 23 Netherlands: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 24 Russia: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 25 Russia: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 26 Asia Pacific: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 27 Asia Pacific: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 28 China: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 29 China: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 30 India: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 31 India: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 32 Malaysia: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 33 Malaysia: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 34 Japan: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 35 Japan: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 36 Indonesia: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 37 Indonesia: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 38 South Korea: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 39 South Korea: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 40 Middle East & Africa: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 41 Middle East & Africa: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 42 Saudi Arabia: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 43 Saudi Arabia: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 44 UAE: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 45 UAE: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 46 Israel: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 47 Israel: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 48 South Africa: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 49 South Africa: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 50 Latin America: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 51 Latin America: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 52 Mexico: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 53 Mexico: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 54 Brazil: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 55 Brazil: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
Table 56 Argentina: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
Table 57 Argentina: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)

List of Figures

Figure 1 Global Cell Therapy Human Raw Materials Market, 2019-2032 (USD Billion)
Figure 2 Integrated Ecosystem
Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
Figure 4 Market by Geography
Figure 5 Porter’s Five Forces
Figure 6 Market by End-User
Figure 7 Global Cell Therapy Human Raw Materials Market, by End-User, 2022 & 2032 (USD Billion)
Figure 8 Market by Product
Figure 9 Global Cell Therapy Human Raw Materials Market, by Product, 2022 & 2032 (USD Billion)
Figure 10 Cell Therapy Human Raw Materials Market Assessment, By Geography, 2019-2032 (USD Billion)
Figure 11 Strategic Analysis – Cell Therapy Human Raw Materials Market

Report Scope

Cell Therapy Human Raw Materials Market, Product Outlook (Revenue - USD Billion, 2019-2032)

Cell Culture Media
Cell Culture Supplements
Cell Culture Sera
Reagents & Buffers
Others

Cell Therapy Human Raw Materials Market, End-User Outlook (Revenue - USD Billion, 2019-2032)

Biopharmaceutical & Pharmaceutical Companies
CROs & CMOs
Academic & Research Institutions

Cell Therapy Human Raw Materials Market, Regional Outlook (Revenue - USD Billion, 2019-2032)

North America
- Product Outlook
  - Cell Culture Media
  - Cell Culture Supplements
  - Cell Culture Sera
  - Reagents & Buffers
  - Others
- End-User Outlook
  - Biopharmaceutical & Pharmaceutical Companies
  - CROs & CMOs
  - Academic & Research Institutions
Europe
- Product Outlook
  - Cell Culture Media
  - Cell Culture Supplements
  - Cell Culture Sera
  - Reagents & Buffers
  - Others
- End-User Outlook
  - Biopharmaceutical & Pharmaceutical Companies
  - CROs & CMOs
  - Academic & Research Institutions
Asia Pacific
- Product Outlook
  - Cell Culture Media
  - Cell Culture Supplements
  - Cell Culture Sera
  - Reagents & Buffers
  - Others
- End-User Outlook
  - Biopharmaceutical & Pharmaceutical Companies
  - CROs & CMOs
  - Academic & Research Institutions
Latin America
- Product Outlook
  - Cell Culture Media
  - Cell Culture Supplements
  - Cell Culture Sera
  - Reagents & Buffers
  - Others
- End-User Outlook
  - Biopharmaceutical & Pharmaceutical Companies
  - CROs & CMOs
  - Academic & Research Institutions
Middle East & Africa
- Product Outlook
  - Cell Culture Media
  - Cell Culture Supplements
  - Cell Culture Sera
  - Reagents & Buffers
  - Others
- End-User Outlook
  - Biopharmaceutical & Pharmaceutical Companies
  - CROs & CMOs
  - Academic & Research Institutions

Qualitative Analysis

Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL Analysis
- Value Chain Analysis
- Key market opportunities prioritized
Competitive landscape
- Overview
- Financials
- Product benchmarking
- Latest strategic developments
- Price Trend Analysis

Quantitative Analysis

Market size, estimates, and forecasts from 2019-2032
Market revenue estimates for Product up to 2032
Market revenue estimates for End-User up to 2032
Regional market size and forecast up to 2032
Company financials

Request Free Sample

We take great pride in "Delivering game-changing business opportunities reports with report customizations", so please don't hesitate to share with us your unique interests and business difficulties in much more detail.

By using this form you agree with the storage and handling of your data by this website.

This website is secure and your personal details are safe. Privacy Policy

Cell Therapy Human Raw Materials Market Size Report, 2024-2032

What's Included in Full Report?

Request Sample Report